Cardiovascular disease remains the leading cause of death globally, yet one of its most fundamental diagnostic tools — the electrocardiogram — has long been constrained by the limits of human pattern recognition. An integrative review published in Diagnostics now maps how deep learning is systematically dismantling those constraints, with implications for earlier detection, remote monitoring, and populations historically underserved by specialist cardiology.
The review synthesizes recent developments in AI-enabled ECG interpretation across three core domains: arrhythmia detection, structural heart disease identification, and digital biomarker derivation from raw waveform data. Foundation models — large-scale architectures pre-trained on vast ECG datasets — are a focal point, as is the shift toward self-supervised learning, which reduces dependence on costly expert-labeled training data. Multimodal integration, combining ECG signals with imaging or clinical metadata, and generative models capable of augmenting rare-condition datasets, are identified as emerging frontiers. Critically, the review also addresses algorithmic bias and generalizability failures, noting that models trained on demographically narrow datasets may underperform across age groups, sexes, and ethnicities — a non-trivial clinical risk.
This landscape review arrives at a moment when wearable ECG devices are proliferating in consumer markets, making AI interpretation infrastructure increasingly consequential for public health. The finding that AI can extract "high-dimensional patterns" correlating with systemic conditions beyond cardiac disease — potentially including metabolic and endocrine disorders — hints at a future where a standard 10-second ECG strip may carry diagnostic information far exceeding its traditional scope. That said, this is a narrative integrative review, not a meta-analysis or primary trial, meaning its strength lies in synthesis rather than quantified effect sizes. The persistent gaps flagged — curated open datasets, resource-constrained deployment, and regulatory harmonization — remain genuine bottlenecks to clinical translation. Incremental in isolation, but collectively these advances signal a meaningful inflection point in cardiac diagnostics.